Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. DYAI
DYAI logo

DYAI Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Dyadic International Inc (DYAI) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Sell
Latest Price
0.790
1 Day change
0.76%
52 Week Range
1.350
Analysis Updated At
2026/05/01
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

DYAI is not a good buy right now for a beginner long-term investor with $50,000-$100,000 available. The stock has weak technical momentum, deteriorating fundamentals, no supportive news catalyst, and no meaningful bullish institutional or insider activity. Even though the stock is near short-term support and options sentiment is neutral, the overall setup does not justify buying now. Based on the data, the better call is to avoid initiating a long-term position at this time.

Technical Analysis

Technical trend is bearish. MACD histogram is -0.012 and negatively expanding, showing weakening momentum. RSI_6 at 34.898 is neutral but closer to oversold than strong bullish territory. Moving averages are bearish with SMA_200 > SMA_20 > SMA_5, which confirms a downtrend. Price at 0.7845 is below the pivot of 0.821 and only slightly above S1 at 0.733, so the stock is trading near support rather than breaking into strength. The near-term pattern data suggests only modest upside probabilities, not a strong trend reversal.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options sentiment is neutral-to-lightly bullish on paper because put-call ratios are 0.0, but the practical signal is weak since todays volume is 0 and open interest is only 759 calls with no puts shown. Implied volatility is very high at 347.81, suggesting speculative pricing rather than strong conviction. The absence of active option flow limits the usefulness of options data as a bullish confirmation.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
10
Buy
1

Positive Catalysts

  • ["Price closed up 3.54% on the session.", "The stock is trading near support, which may allow a short-term bounce.", "Comparable candlestick pattern analysis suggests a modest probability of near-term upside."]

Neutral/Negative Catalysts

  • ["No news in the recent week, so there is no event-driven catalyst.", "Revenue fell 30.81% YoY in Q4 2025.", "Gross margin dropped 43.72% YoY to 31.99.", "Net income remained negative at -1,567,263 despite slight YoY improvement.", "Bearish moving averages and negative MACD momentum signal ongoing weakness.", "Hedge funds are neutral and insiders are neutral, with no significant buying support.", "No recent congress trading data.", "No AI Stock Picker or SwingMax bullish signal today."]

Financial Performance

In Q4 2025, DYAI showed weak operating performance. Revenue declined to 565,526, down 30.81% YoY, which is a meaningful contraction. Net income was still negative at -1,567,263, although it improved slightly by 1.06% YoY. EPS improved to -0.06, but the business is still unprofitable. Gross margin fell sharply to 31.99, down 43.72% YoY, which points to deteriorating core economics. Overall, the latest quarter season was weak and does not support a long-term buy case.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data was provided, so there is no evidence of a recent bullish revision. Wall Street pros appear neutral at best based on the lack of support from analyst activity, while the absence of upgrades, target increases, or positive coverage momentum leaves the stock without a clear professional endorsement.

Wall Street analysts forecast DYAI stock price to rise
Analyst Rating
0
Wall Street analysts forecast DYAI stock price to rise
Buy
Hold
Sell
0
Current: 0.790
sliders
Low
0
Averages
0
High
0
0
Current: 0.790
sliders
Low
0
Averages
0
High
0
H.C. Wainwright
Swayampakula Ramakanth
NULL -> Buy
initiated
$3
AI Analysis
2025-10-23
Reason
H.C. Wainwright
Swayampakula Ramakanth
Price Target
$3
AI Analysis
2025-10-23
initiated
NULL -> Buy
Reason
H.C. Wainwright analyst Swayampakula Ramakanth assumed coverage of Dyadic International with a Buy rating and $3 price target. The company produces recombinant proteins based on proprietary fungus-based platforms, the analyst tells investors in a research note. The firm is "encouraged" by Dyadic's efforts to expand its platform into further non-pharmaceutical applications and views them as upside to estimates.
Craig-Hallum
Matthew Hewitt
initiated
$5
2025-09-08
Reason
Craig-Hallum
Matthew Hewitt
Price Target
$5
2025-09-08
initiated
Reason
Craig-Hallum analyst Matthew Hewitt initiated coverage of Dyadic International with a Buy rating and $5 price target.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for DYAI
Unlock Now

People Also Watch